A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

被引：3
|
作者：
Burke, Michael J. [1 ]
Lamba, Jatinder
Weigel, Brenda
Bachanova, Veronika
Verneris, Michael R. [2 ]
Miller, Jeffrey S. [3 ]
机构：
[1] Univ Minnesota, Div Hematol Oncol, Minneapolis, MN USA
[2] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4307.4307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4307
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia
    Burke, Michael J.
    Lamba, Jatinder K.
    Pounds, Stanley
    Cao, Xueyuan
    Ghodke-Puranik, Yogita
    Lindgren, Bruce R.
    Weigel, Brenda J.
    Verneris, Michael R.
    Miller, Jeffrey S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (09) : 889 - 895
  • [2] Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study
    Burke, Michael J.
    Kostadinov, Rumen
    Sposto, Richard
    Gore, Lia
    Kelley, Shannon M.
    Rabik, Cara
    Trepel, Jane B.
    Lee, Min-Jung
    Yuno, Akira
    Lee, Seonju
    Bhojwani, Deepa
    Jeha, Sima
    Chang, Bill H.
    Sulis, Maria Luisa
    Hermiston, Michelle L.
    Gaynon, Paul
    Van Huynh
    Verma, Anupam
    Gardner, Rebecca
    Heym, Kenneth M.
    Dennis, Robyn M.
    Ziegler, David S.
    Laetsch, Theodore W.
    Oesterheld, Javier E.
    Dubois, Steven G.
    Pollard, Jessica A.
    Glade-Bender, Julia
    Cooper, Todd M.
    Kaplan, Joel A.
    Farooqi, Midhat S.
    Yoo, Byunggil
    Guest, Erin
    Wayne, Alan S.
    Brown, Patrick A.
    CLINICAL CANCER RESEARCH, 2020, 26 (10) : 2297 - 2307
  • [3] A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia
    Litzow, Mark R.
    Lee, Sandra
    Bennett, John M.
    Dewald, Gordon W.
    Gallagher, Robert E.
    Jain, Vibha
    Paietta, Elisabeth M.
    Racevskis, Janis
    Rousey, Steven R.
    Mazza, Joseph J.
    Tallman, Martin S.
    HAEMATOLOGICA, 2006, 91 (08) : 1105 - 1108
  • [4] Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia
    Miyagawa, Naoyuki
    Goto, Hiroaki
    Ogawa, Atsushi
    Kikuta, Atsushi
    Kosaka, Yoshiyuki
    Sekimizu, Masahiro
    Tomizawa, Daisuke
    Toyoda, Hidemi
    Hiramatsu, Hidefumi
    Hara, Junichi
    Mochizuki, Shinji
    Nakayama, Hideki
    Yoshimura, Kenichi
    Iijima-Yamashita, Yuka
    Sanada, Masashi
    Ogawa, Chitose
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 267 - 276
  • [5] Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia
    Naoyuki Miyagawa
    Hiroaki Goto
    Atsushi Ogawa
    Atsushi Kikuta
    Yoshiyuki Kosaka
    Masahiro Sekimizu
    Daisuke Tomizawa
    Hidemi Toyoda
    Hidefumi Hiramatsu
    Junichi Hara
    Shinji Mochizuki
    Hideki Nakayama
    Kenichi Yoshimura
    Yuka Iijima-Yamashita
    Masashi Sanada
    Chitose Ogawa
    International Journal of Hematology, 2023, 118 : 267 - 276
  • [6] A phase II trial of arsenic trioxide (AT) for relapsed and refractory acute lymphoblastic leukemia (ALL).
    Litzow, MR
    Lee, S
    Bennett, JM
    Gallagher, RE
    Paietta, EM
    Rousey, SR
    Tallman, MS
    BLOOD, 2003, 102 (11) : 260B - 260B
  • [7] Ruxolitinib or Dasatinib in Combination with Chemotherapy for Patients with Relapsed/Refractory Philadelphia (Ph)-like Acute Lymphoblastic Leukemia: A Phase I-II Trial
    Jain, Nitin
    Jabbour, Elias J.
    McKay, Patrick Zweider
    Ravandi, Farhad
    Takahashi, Koichi
    Kadia, Tapan
    Wierda, William G.
    Rytting, Michael E.
    Nunez, Cesar
    Patel, Keyur
    Lu, Xinyan
    Tang, Guilin
    Konoplev, Sergej Naumovich
    Wang, Sa A.
    Han, Lina
    Thakral, Beenu
    Roberts, Kathryn G.
    Deshmukh, April
    Garris, Rebecca
    Jorgensen, Jeffrey L.
    Cavazos, Antonio
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    O'Brien, Susan M.
    Cortes, Jorge E.
    Mullighan, Charles G.
    Kantarjianand, Hagop M.
    Konopleva, Marina
    BLOOD, 2017, 130
  • [8] Venetoclax and navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
    Pullarkat, Vinod A.
    Lacayo, Norman J.
    Jabbour, Elias
    Rubnitz, Jeffrey E.
    Bajel, Ashish
    Laetsch, Theodore W.
    Leonard, Jessica
    Colace, Susan, I
    Khaw, Seong Lin
    Fleming, Shaun A.
    Mattison, Ryan J.
    Norris, Robin
    Opferman, Joseph T.
    Roberts, Kathryn G.
    Zhao, Yaqi
    Qu, Chunxu
    Badawi, Mohamed
    Schmidt, Michelle
    Tong, Bo
    Pesko, John C.
    Sun, Yan
    Ross, Jeremy A.
    Vishwamitra, Deeksha
    Rosenwinkel, Lindsey
    Kim, Su Young
    Jacobson, Amanda
    Mullighan, Charles G.
    Alexander, Thomas B.
    Stock, Wendy
    CANCER DISCOVERY, 2021, 11 (06) : 1440 - 1453
  • [9] A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Daver, Naval
    Boumber, Yanis
    Kantarjian, Hagop
    Ravandi, Farhad
    Cortes, Jorge
    Rytting, Michael E.
    Kawedia, Jitesh D.
    Basnett, Jordan
    Culotta, Kirk S.
    Zeng, Zhihong
    Lu, Hongbo
    Richie, Mary Ann
    Garris, Rebecca
    Xiao, Lianchun
    Liu, Wenbin
    Baggerly, Keith A.
    Jabbour, Elias
    O'Brien, Susan
    Burger, Jan
    Bendall, Linda J.
    Thomas, Deborah
    Konopleva, Marina
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2704 - 2714
  • [10] A phase II feasibility study of cytarabine and idarubicin combination in relapsed or refractory adult acute lymphoblastic leukemia
    Hafeez, M.
    Shaharyar, A.
    Zia, N.
    Rasheed, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345